Sobi, Inc.

Industry · 7 registered clinical trials.

Status	Trial	Phase	Started
Completed	Evaluation of Avatrombopag for the Treatment of Thrombocytopenia in Japanese Adults With Chronic ITP Immune Thrombocytopenia	Phase 3	2022-06-15
Withdrawn	Open-Label Study to Evaluate the Safety and Efficacy of Avatrombopag and Remission Rates in Adults With ITP of Immune Thrombocytopenia	Phase 3	2021-10-14
Completed	Safety and Treatment Satisfaction in Adults With Chronic ITP After Switching to Avatrombopag From Eltrombopag Immune Thrombocytopenia	Phase 4	2021-03-15
Completed	Avatrombopag for the Treatment of Thrombocytopenia in Pediatric Subjects With Immune Thrombocytopenia for ≥6 M Immune Thrombocytopenia	Phase 3	2021-03-05
Completed	Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematologica Chemotherapy-induced Thrombocytopenia	Phase 3	2018-10-12
Terminated	Avatrombopag for the Treatment of Thrombocytopenia in Adults With Chronic Liver Disease Undergoing a Procedure Thrombocytopenia	—	2018-07-02
Terminated	Avatrombopag for the Treatment of Thrombocytopenia in Adults Scheduled for a Surgical Procedure Thrombocytopenia	Phase 3	2018-03-26